Connection

Robert Leman to Male

Back to Details
This is a "connection" page, showing publications Robert Leman has written about Male.
Robert Leman
Connection Strength
0.140
Male
  1. The Effect of Chronic Kidney Disease on Mortality with Cardiac Resynchronization Therapy. Pacing Clin Electrophysiol. 2016 Aug; 39(8):863-9.
    View in: PubMed
    Score: 0.007
  2. The impact of device recall on patients and family members of patients with automatic implantable cardioverter defibrillators. Heart Lung. 1994 Jul-Aug; 23(4):317-22.
    View in: PubMed
    Score: 0.006
  3. The effect of left ventricular electrical delay on the acute hemodynamic response with cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2014 Jun; 25(6):624-30.
    View in: PubMed
    Score: 0.006
  4. Cerebral monitoring during implantation of automatic internal cardiac defibrillators. South Med J. 1993 May; 86(5):533-6.
    View in: PubMed
    Score: 0.006
  5. Safety of continuous anticoagulation with dabigatran during implantation of cardiac rhythm devices. Am J Cardiol. 2013 Apr 15; 111(8):1165-8.
    View in: PubMed
    Score: 0.006
  6. Prosthetic valve endocarditis due to Cardiobacterium hominis occurring after upper gastrointestinal endoscopy. Am J Med. 1991 Apr; 90(4):516-8.
    View in: PubMed
    Score: 0.005
  7. A prospective, randomized comparison of the acute hemodynamic effects of biventricular and left ventricular pacing with cardiac resynchronization therapy. Heart Rhythm. 2011 May; 8(5):685-91.
    View in: PubMed
    Score: 0.005
  8. Defibrillation thresholds in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2011 May; 22(5):569-72.
    View in: PubMed
    Score: 0.005
  9. Randomized comparison of defibrillation thresholds from the right ventricular apex and outflow tract. Heart Rhythm. 2010 Nov; 7(11):1561-6.
    View in: PubMed
    Score: 0.005
  10. Interventional treatment for ventricular arrhythmias: the initial South Carolina case. J S C Med Assoc. 1990 Jun; 86(6):341-5.
    View in: PubMed
    Score: 0.005
  11. Programming eccentricities of an activity sensing pacemaker. Pacing Clin Electrophysiol. 1990 Jan; 13(1):3-6.
    View in: PubMed
    Score: 0.005
  12. The potential utility of sensor-driven pacing in DDD pacemakers. Am Heart J. 1989 Nov; 118(5 Pt 1):919-23.
    View in: PubMed
    Score: 0.005
  13. Role of transesophageal echocardiography among patients with atrial fibrillation undergoing electrophysiology testing. Am J Cardiol. 2009 Nov 01; 104(9):1256-8.
    View in: PubMed
    Score: 0.005
  14. Acute hemodynamic effects of atrial pacing with cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2009 Aug; 20(8):894-900.
    View in: PubMed
    Score: 0.004
  15. Disparities in preferences for receiving support and education among patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2009 Mar; 32(3):383-90.
    View in: PubMed
    Score: 0.004
  16. The effect of dofetilide on ventricular defibrillation thresholds. Pacing Clin Electrophysiol. 2009 Jan; 32(1):24-8.
    View in: PubMed
    Score: 0.004
  17. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008 Nov 18; 52(21):1718-23.
    View in: PubMed
    Score: 0.004
  18. Optimization of superior vena cava coil position and usage for transvenous defibrillation. Heart Rhythm. 2008 Mar; 5(3):394-9.
    View in: PubMed
    Score: 0.004
  19. Predictors of outcome for aortic valve replacement in patients with aortic regurgitation and left ventricular dysfunction: a change in the measuring stick. J Am Coll Cardiol. 1987 Nov; 10(5):991-7.
    View in: PubMed
    Score: 0.004
  20. A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2007 May; 18(5):490-6.
    View in: PubMed
    Score: 0.004
  21. Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial. J Natl Med Assoc. 2006 Mar; 98(3):330-9.
    View in: PubMed
    Score: 0.004
  22. Radionuclide evaluation of dual chamber pacing: comparison between variable AV intervals and ventricular pacing. Pacing Clin Electrophysiol. 1985 May; 8(3 Pt 1):408-14.
    View in: PubMed
    Score: 0.003
  23. Relation of initial resting ventricular rate to the ability to achieve and maintain normal sinus rhythm in patients with atrial fibrillation. Am J Cardiol. 2005 Mar 01; 95(5):597-602.
    View in: PubMed
    Score: 0.003
  24. Time to resumption of driving after implantation of an automatic defibrillator (from the Dual chamber and VVI Implantable Defibrillator [DAVID] trial). Am J Cardiol. 2005 Mar 01; 95(5):665-6.
    View in: PubMed
    Score: 0.003
  25. Efficacy of transthoracic cardioversion of atrial fibrillation using a biphasic, truncated exponential shock waveform at variable initial shock energies. Am J Cardiol. 2004 Dec 15; 94(12):1572-4.
    View in: PubMed
    Score: 0.003
  26. Clinical investigation of a new dual-chamber implantable cardioverter defibrillator with improved rhythm discrimination capabilities. J Cardiovasc Electrophysiol. 2003 Feb; 14(2):144-9.
    View in: PubMed
    Score: 0.003
  27. Myocardial preservation by thrombolytic therapy during acute MI. South Med J. 1983 Jan; 76(1):71-5.
    View in: PubMed
    Score: 0.003
  28. Safety of a single successful conversion of ventricular fibrillation before the implantation of cardioverter defibrillators. Pacing Clin Electrophysiol. 2003 Jan; 26(1P2):483-6.
    View in: PubMed
    Score: 0.003
  29. Driving with an internal defibrillator: legal, ethical, and quality-of-life issues. J Cardiovasc Nurs. 1997 Jan; 11(2):58-67.
    View in: PubMed
    Score: 0.002
  30. Driving safety among patients with automatic implantable cardioverter defibrillators. JAMA. 1993 Oct 06; 270(13):1587-8.
    View in: PubMed
    Score: 0.002
  31. Chronotropic incompetence: a common and progressive finding in pacemaker patients. Am Heart J. 1992 May; 123(5):1216-9.
    View in: PubMed
    Score: 0.001
  32. Single- versus dual-chamber sensor-driven pacing: comparison of cardiac outputs. Am Heart J. 1991 Sep; 122(3 Pt 1):728-32.
    View in: PubMed
    Score: 0.001
  33. Catheter-induced tricuspid regurgitation. Incidence and clinical significance. Chest. 1991 Mar; 99(3):651-5.
    View in: PubMed
    Score: 0.001
  34. Efficacy and safety of sustained-release diltiazem as replacement therapy for beta blockers and diuretics for stable angina pectoris and coexisting essential hypertension: a multicenter trial. Am J Cardiol. 1987 Dec 14; 60(17):29I-35I.
    View in: PubMed
    Score: 0.001
  35. Association of a porcine mitral valve with development of a left ventricular aneurysm. J S C Med Assoc. 1987 Sep; 83(9):485-6.
    View in: PubMed
    Score: 0.001
  36. Limitations of the long-term clinical application of rate hysteresis. Pacing Clin Electrophysiol. 1987 Mar; 10(2):302-4.
    View in: PubMed
    Score: 0.001
  37. An argument for pacemaker reuse: pacemaker mortality in 169 patients over ten years. Pacing Clin Electrophysiol. 1986 Nov; 9(6 Pt 2):1295-8.
    View in: PubMed
    Score: 0.001
  38. Use of combined calcium channel blockers for therapy of refractory angina pectoris. J S C Med Assoc. 1986 Feb; 82(2):65-8.
    View in: PubMed
    Score: 0.001
  39. Steroid treatment of the painful pacemaker pocket. Pacing Clin Electrophysiol. 1984 Jan; 7(1):71-3.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.